Insulin glargine and glulisine SoloSTAR^® pens for the treatment of diabetes

Abstract

Insulin is an effective medication for lowering hemoglobin A_1c values and can be used for both basal and prandial coverage of hyperglycemia in Type 1 and Type 2 diabetes. Despite its effectiveness there is still reluctance by patients and physicians to add insulin into the treatment regimen for Type 2 diabetes when needed. One of the key barriers to initiating insulin therapy is the method of delivery. Insulin delivery pens are continually developed as a means to improve upon the vial and syringe and to make it easier for patients to incorporate insulin therapy into their lifestyles. The SoloSTAR^® pen (Sanofi-Aventis, Paris, France) was developed to make insulin delivery easier and to help eliminate barriers to the initiation of insulin therapy. In this article, we discuss the features and characteristics of SoloSTAR that overcome existing unmet needs.

Keywords::

• diabetes
• hypoglycemia
• injection force
• insulin
• insulin dose
• SoloSTAR^® pen

Financial & competing interests disclosure

This study was supported by Sanofi-Aventis. Satish Garg is a member of the advisory board for Eli Lilly and Company, Novo Nordisk, Pfizer, Merck, Sanofi-Aventis, DexCom, MiniMed, Abbott, NIH, JDRF and ADA. He is on the speaker Bureau and has received honoraria from Eli Lilly and Company, Novo Nordisk, Pfizer, Merck, Sanofi-Aventis, DexCom, MiniMed, Abbott, NIH, JDRF and ADA. He has received research grants from Eli Lilly and Company, Novo Nordisk, Pfizer, Merck, Sanofi-Aventis, DexCom, MiniMed, Abbott, NIH, JDRF and ADA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing assistance was utilized in the production of this manuscript. Editorial support for this manuscript was provided by the Global Publications group of Sanofi-Aventis.

Notes

HbA^1c: Hemoglobin A_1c.

From [10].